PrecisionOp

Improve the perioperative process – more personalization means fewer adverse drug reactions and the potential for less reliance on post-operative opioids.

Perioperative Risk Assessment

Enhance pain management throughout the entire operative process by embracing a personalized approach.

Through pharmacogenetics testing, providers now have the tools and resources to reduce adverse drug reactions and lower dependency on post-operative opioids.

Our solutions ensure providers have truly personalized options for optimized recovery for their patients.

Using targeted genetic markers and a patient’s unique information (i.e., demographic information and clinical history), the PrecisionOp platform offers a customized solution. We provide personalized recommendations with opioid-sparing options, promoting post-surgical recovery, and increasing patient satisfaction.

Did You Know?

0 M

Surgeries Annually

Of the estimated 80 million surgeries performed annually, complications from prescription mismanagement for postoperative pain contribute to ADRs, prolonged hospital stay, readmissions, and overuse of opioids.¹

$ 0 B

Spent on medications

$528B spent on non-optimized medication use and medication-related problems.²

0 %

Experience adverse reactions

20% of patients experience adverse events within three weeks of discharge.³

0 th

Leading cause of death

Adverse drug reactions (ADRs) are the 4th leading cause of death, with approximately 1.3M ED visits of those 350K patients hospitalized.⁴

Contact us to help reduce adverse drug reactions.

¹80 million surgeries performed annually, complications from prescription mismanagement for postoperative pain contribute to ADRs, prolonged hospital stay, readmissions, and overuse of opioids (citation: Koepke EJ, Manning EL, Miller TE, Ganesh A, Williams DGA, Manning MW. The rising tide of opioid use and abuse: the role of the anesthesiologist. Perioper Med. 2018;7(1):1-10. doi:10.1186/s13741-018-0097-4)
²$528 billion estimated to be spent annually in the United States on drug-related morbidity and mortality resulting from nonoptimized medication therapy (citation: Watanabe JH, McInnis T, Hirsch JD. Cost of Prescription Drug-Related Morbidity and Mortality. Ann Pharmacother. 2018;52(9):829-837. doi:10.1177/1060028018765159)
³20% of patients experience adverse events within three weeks of discharge, with adverse drug reactions accounting for nearly two thirds of such events (citation: Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med. 2003;138(3):161-167. doi:10.7326/0003-4819-138-3-200302040-00007)
⁴Adverse drug reactions have been estimated to be as high as the 4th leading cause of death in the United States and represent a leading clinical issue in the perioperative arena (citation: Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200-1205. doi:10.1001/jama.279.15.1200)